|Day's Range||35.06 - 35.17|
|52 Week Range||23.00 - 36.49|
|PE Ratio (TTM)||18.15|
|Dividend & Yield||0.86 (2.45%)|
|1y Target Est||35.77|
The luxury homebuilder topped Q2 earnings and sales growth forecasts. But shares of Toll Bros. and several other builders reversed to close lower, in part due to plunging new-home sales data.
Health care technology giant Koninklijke Philips has reached a deal to buy Twin Cities medical-device maker RespirTech for an undisclosed amount. Roseville-based RespirTech makes the inCourage line of airway-clearance vests, which treat chronic lung conditions such as cystic fibrosis. The deal will let Philips expand further into the market for treating conditions such as chronic obstructive pulmonary disease, the company said in a news release.
AMSTERDAM, May 22, 2017 /PRNewswire/ -- Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly ...